01. Service Overview — EU GMP-Aligned mAb Manufacturing Facility Solutions
We deliver professional, regulation-driven facility design services exclusively tailored for monoclonal antibody manufacturing, fully complying with EU GMP Annex 1, EMA regulatory guidelines and global cGMP standards. Our design coverage spans full-process mAb production facilities, including upstream cell culture zones, midstream clarification areas, downstream purification workshops, buffer and media preparation rooms, and classified sterile storage areas. Unlike conventional general biopharma facility design, our solutions focus on the unique production characteristics of mAb products, strict cross-contamination control, dynamic environmental monitoring and standardized aseptic operation management, building fully audit-ready, EU-standard compliant manufacturing environments for global market registration and commercial production.
02. Core Competencies — EU Standard Precision Implementation & mAb Process Adaptable Layout
Our core strengths lie in the in-depth integration of EU GMP stringent specifications and professional monoclonal antibody process requirements. EU GMP imposes rigorous and updated standards for cleanroom classification, pressure gradient maintenance, airborne particle and microbial control, personnel and material flow isolation, and facility sanitization management for biologic drug production. Our interdisciplinary engineering team adopts targeted design strategies for mAb high-density culture, high-load purification and low-loss production demands. We optimize hierarchical clean zone partitioning, unidirectional workflow layout, independent utility systems and full-process contamination isolation mechanisms, eliminating common industry pain points such as standard mismatch, layout irrationality and regulatory audit risks.
03. Full Lifecycle Standardized Engineering Design Services
We provide one-stop full-lifecycle engineering services for EU GMP-compliant mAb facilities, including project compliance gap analysis, site master planning, conceptual and detailed engineering design, cleanroom and HVAC system optimization, sanitary piping and utility layout, process equipment matching design, performance qualification scheme formulation, and complete EU GMP validation document delivery. We support greenfield mAb plant construction, existing antibody facility renovation, and standard upgrading to meet EU regulatory requirements. All design outputs follow standardized, traceable and construction-oriented principles to ensure seamless docking with subsequent construction, commissioning and validation.
04. Core Value — EU Market Access, Batch Stability & Long-Term Regulatory Compliance
Our EU GMP compliant mAb facility design delivers core regulatory and commercial value for biopharmaceutical enterprises. Strict implementation of EU GMP specifications eliminates compliance loopholes, supporting smooth product certification, registration and market entry in the European Union and other high-end global markets. Process-matched facility layout effectively stabilizes mAb production quality, improves batch-to-batch consistency, and reduces contamination and product loss risks. Forward-looking standardized design adapts to continuous EU regulatory updates and product iteration, helping enterprises build high-standard, stable and future-proof monoclonal antibody commercial manufacturing platforms and enhance global industry competitiveness.
